Rüdiger M.
- Country
- Germany
- Department
- Institut für Präventive Medizin & Klinische Forschung GbR
Research Overview
- Phase 3 Randomized Double‑Masked Placebo‑Controlled Study of Subcutaneous Efgartigimod Alfa in Adults with Graves’ Disease Inadequately Controlled by Antithyroid Drugs
- Dose-Response Evaluation of Dronabinol (VER-01) in Chronic Non-Specific Low Back Pain Unresponsive to Non-Opioid Analgesics
- Phase IV Randomized, Double-Blind, Placebo-Controlled Study of Inclisiran with Lipid-Lowering Therapy in Hypercholesterolemia Patients
Data & Insights
Has run more than one trial at 215 of 877 partner sites.
Specializations
Rheumatology
Clinical research in rheumatoid arthritis, psoriatic arthritis, and non-radiographic axial spondyloarthritis, with attention to inflammatory disease control and symptom reduction.
- Rheumatoid arthritis
- Psoriatic arthritis
- Non-radiographic axial spondyloarthritis
- Inflammatory joint disease
Work in this area includes therapeutic evaluation of agents used to manage active disease and maintain remission in chronic immune-mediated conditions.
Cardiometabolic disease
Investigator activity includes studies in cardiovascular disease, hypertension, and type 2 diabetes, with a focus on reducing major cardiovascular risk and improving disease outcomes.
- Cardiovascular disease
- Hypertension
- Type 2 diabetes
- Heart failure risk
Therapeutic interest extends to combinations and strategies aimed at preventing cardiovascular events in patients with established cardiometabolic burden.
Lipid disorders
Research involvement covers hypercholesterolemia and lipoprotein(a)-related cardiovascular risk, with emphasis on achieving individualized lipid targets and lowering atherosclerotic risk.
- Hypercholesterolemia
- Lipoprotein(a)
- LDL-C target attainment
- Atherosclerotic risk reduction
This field reflects a therapeutic interest in advanced lipid-lowering approaches for patients requiring intensified cardiovascular prevention.
Pain management
Clinical trial activity includes treatment research for chronic non-specific low back pain, particularly in patients who have not achieved sufficient relief with prior non-opioid therapy.
- Chronic low back pain
- Non-opioid treatment limitations
- Pain reduction
The therapeutic focus is centered on options for persistent musculoskeletal pain where conventional analgesic strategies are inadequate or unsuitable.
Venous thromboembolism safety
Additional research interest includes venous thromboembolism risk assessment in rheumatoid arthritis treatment, linking anti-inflammatory therapy with cardiovascular and hematologic safety considerations.
- Venous thromboembolism
- Treatment safety
- Rheumatoid arthritis therapy
This area connects immune-mediated disease management with monitoring of clinically important thrombotic outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.